Envista Holdings (NVST) Capital Expenditures (2018 - 2026)
Envista Holdings' (NVST) quarterly Capital Expenditures came in at $12.5 million in Q2 2026, up 111.86% year-on-year from $5.9 million in Q2 2025, and down 23.31% quarter-over-quarter from $16.3 million in Q4 2025.
Envista Holdings (NVST) Capital Expenditures (2018 - 2026) Analysis & Trends
Envista Holdings' Capital Expenditures history runs 9 years deep, the most recent figure standing at $12.5 million for Q2 2026.
- On a quarterly basis, Capital Expenditures rose 111.86% year-over-year to $12.5 million in Q2 2026; TTM through Apr 2026 was $51.9 million, a 80.84% increase from a year earlier, with the FY2025 full-year figure at $45.3 million, up 34.02% from the prior year.
- Capital Expenditures declined to $12.5 million in Q2 2026 per NVST's latest filing, from $16.3 million in the prior quarter.
- Across five years, Capital Expenditures topped out at $26.9 million in Q3 2022 and bottomed at $5.9 million in Q1 2025.
- The 5-year median for Capital Expenditures is $12.3 million (2025), against an average of $13.3 million.
- Across the five-year window, Capital Expenditures surged 138.55% in 2022 and plunged 59.78% in 2024, its largest moves.
- Year by year, Capital Expenditures stood at $16.9 million in 2022, then tumbled by 51.48% to $8.2 million in 2023, then climbed by 4.88% to $8.6 million in 2024, then jumped by 89.53% to $16.3 million in 2025, then decreased by 23.31% to $12.5 million in 2026.
- Per Business Quant, the three latest NVST Capital Expenditures figures stand at $12.5 million (Q2 2026), $16.3 million (Q4 2025), and $10.8 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | -139.00 Mn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | -34.50 Mn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 125.00 Mn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 96.00 Mn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 33.65 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 43.20 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 86.40 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 84.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 30.79 Mn |
| 10 | Envista Holdings | 4.29 Bn | 3.20 Bn | 390.10 Mn | 12.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 12.50 Mn |
| Apr 3, 2026 | 12.50 Mn |
| Dec 31, 2025 | 16.30 Mn |
| Dec 31, 2025 | 16.30 Mn |
| Sep 26, 2025 | 10.80 Mn |
| Sep 26, 2025 | 10.80 Mn |
| Jun 27, 2025 | 12.30 Mn |
| Jun 27, 2025 | 12.30 Mn |
| Mar 28, 2025 | 5.90 Mn |
| Mar 28, 2025 | 5.90 Mn |
| Dec 31, 2024 | 8.60 Mn |
| Dec 31, 2024 | 8.60 Mn |
| Sep 27, 2024 | 7.40 Mn |
| Sep 27, 2024 | 7.40 Mn |
| Jun 28, 2024 | 6.80 Mn |
| Jun 28, 2024 | 6.80 Mn |
| Mar 29, 2024 | 11.00 Mn |
| Mar 29, 2024 | 11.00 Mn |
| Dec 31, 2023 | 8.20 Mn |
| Dec 31, 2023 | 8.20 Mn |